Skip to content
DataLookout
Menu

NCT06965933

Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 34 participants (planned 68)
    • Study completion date changed from estimate of Jul 2026 to Aug 10, 2026
    • Secondary endpoints: details revised at 1 of 6 entries
  2. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Study completion pushed from May 2026 to Jul 2026
    • Primary completion date changed from estimate of May 2026 to Apr 20, 2026
    • Site details revised
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2025 to May 20, 2025
    • Site details revised
    v3
  4. Minor Secondary endpoints: details revised at 1 of 6 entriesv2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Time before emergency pain relief (opioid).
Timeframe: 24 hours postoperatively

Secondary (6)

the need for opioids in the postoperative period within 24 hours
pain level assessment using pain scales (Wong-Baker Faces Pain Rating Scale)
assessment of intraoperative analgesia quality (pulse)
assessment of intraoperative analgesia quality (BP)
Complications associated with intravenous lidocaine infusion (general toxic effects on the cardiovascular and central nervous systems)
Show 1 moreShow less
Complications associated with spinal straightening plane block (ESPB)

Arms and interventions

Blockade of the plane straightening the spine (Erector Spinae Plane Block, ESPB).Experimental
IV LidocaineActive comparator

Procedures: ESP block group

Drugs: IV Lidocaine

Sites

1 site in 1 country

  • SaintPetersburgSUSaint Petersburg, Sankt-Peterburg, Russia